DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)

South Korea flag South Korea · Delayed Price · Currency is KRW
14,690
-440 (-2.91%)
At close: Mar 19, 2026
Market Cap257.32B +35.9%
Revenue (ttm)149.47B +1.1%
Net Income39.73M
EPS2.27
Shares Out17.52M
PE Ratio6,477.29
Forward PEn/a
Dividend150.00 (1.02%)
Ex-Dividend DateDec 29, 2025
Volume51,557
Average Volume190,834
Open14,770
Previous Close15,130
Day's Range14,680 - 14,900
52-Week Range12,610 - 24,900
Beta-0.30
RSI47.28
Earnings DateMar 20, 2026

About DAE HWA Pharmaceutical

DAE HWA Pharmaceutical Co., Ltd., a pharmaceutical company, produces and supplies pharmaceutical products in South Korea. The company offers drugs for anticancer, antibiotics, antifungal and skin ailment, antivirus, anti-allergosis, hemorrhoids, antidepressant, antiepileptic, psychotropic agent, anti respiratory, anti-inflammatory, analgesic, skeletal muscle relaxants, osteoporosis, anti-arthritis, gastro-intestinal, obesity, antispasmodic, diabetics, hypertension, hyperlipemia, antithrombotic and anticoagulant, hepatic, erectile dysfunction, u... [Read more]

Industry Pharmaceutical Preparations
Founded 1984
Employees 308
Stock Exchange KOSDAQ
Ticker Symbol 067080
Full Company Profile

Financial Performance

Financial Statements